American Caresource (ANCI)
American Caresource R&D Expense: 0.00
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ANCI R&D Expense Rankings
| Overall | 99th percentile | 13 of 1764 |
| Sector | 98th percentile | 5 of 413 in Healthcare |
| Industry | 75th percentile | 1 of 4 in Specialized Health Services |
ANCI R&D Expense Range, Past 5 Years
| Minimum | 0.00 | Jun 2007 |
| Maximum | 0.00 | Jun 2007 |
| Average | 0.00 |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these ANCI related companies
ANCI News
American CareSource Introduces Comprehensive Solution for Dialysis Cost Containment
May 07, 6:00AM Business Wire
May 07, 6:00AM Business Wire
American CareSource Announces Release Date of First Quarter 2012 Results
May 02, 11:46AM Business Wire
May 02, 11:46AM Business Wire
$ANCI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3aet
about 27 days ago by MarketBrief
about 27 days ago by MarketBrief
American CareSource Announces Fourth Quarter and Year-End Financial Results for 2011
Mar 08, 5:43PM Business Wire
Mar 08, 5:43PM Business Wire
American CareSource Announces Release Date of Fourth Quarter and Year-End 2011 Results
Feb 16, 11:30AM Business Wire
Feb 16, 11:30AM Business Wire
American Caresource Holdings, Inc. (ANCI) Reports Q3 Loss of $0.38, Sales Fall Y/Y
Nov 14, 5:31PM Street Insider
Nov 14, 5:31PM Street Insider
American CareSource Announces Release Date of Third Quarter 2011 Results
Nov 07, 5:14PM Business Wire
Nov 07, 5:14PM Business Wire
American CareSource billed 67,000 claims during Q2, down from 85,000 year-ago
Aug 12, 5:25AM FlyOnTheWall
Aug 12, 5:25AM FlyOnTheWall
American CareSource Announces Release Date of Second Quarter 2011 Results
Aug 08, 3:50PM Business Wire
Aug 08, 3:50PM Business Wire
http://chart.ly/cgtkpg $ANCI - Lower volume, than I like, but volume is slowly increasing. Charts looks interesting IMO. B/O watch
about 743 days ago by METrades
about 743 days ago by METrades
$ANCI forming a nice base...... risk/reward indicates might be a good buy with a stop below support... watching
about 793 days ago by NimTrades
about 793 days ago by NimTrades
Sold some $ANCI at $2 from yesterday's 1.90 entry. Still think this is longer term hold though.
about 794 days ago by shinobi_trader
about 794 days ago by shinobi_trader
52 week lo watch: $ANCI looks cheap. Big potential upside w/ muted downside due to no leverage. BUT acquisition of big client Viant is ?mark
about 944 days ago by derekbobbe
about 944 days ago by derekbobbe
A few more that I'm watching this week are $ANCI, $JAZZ, $KAT.TO, $NRI.TO
about 1057 days ago by DazeTrader
about 1057 days ago by DazeTrader
http://chart.ly/vd7n32 $ANCI - Breaking out of consolidation area
about 1125 days ago by dummystocks
about 1125 days ago by dummystocks
I know $ANCI is very thinly traded, but daily and weekly look good, been consolidating for a while and now breaking out $$
about 1126 days ago by tradejoker
about 1126 days ago by tradejoker
It's time for my $ANCI to make another run here at the 50/200 DMAs. Still holding 25% from June & Aug.I need an intraday move like the Nassy
about 1142 days ago by Joshua_Hayes
about 1142 days ago by Joshua_Hayes
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ANCI | 0.49 | -0.01 | -2.00% | 8.369M |
| ANAT | 68.95 | -0.26 | -0.38% | 1.851B |
| ANAD | 1.98 | +0.01 | +0.51% | 138.36M |
| ANAC | 5.37 | +0.00 | +0.00% | 169.16M |
| AN | 36.27 | +0.39 | +1.09% | 4.519B |
| AMZN | 212.89 | -2.35 | -1.09% | 96.88B |
| ALLT | 23.89 | -0.31 | -1.28% | 714.79M |
| ALL | 33.57 | +0.14 | +0.42% | 16.73B |
| ALKS | 16.14 | +0.19 | +1.19% | 2.092B |
| ALK | 33.96 | +0.12 | +0.35% | 2.422B |
